Logo image
Back
Stigma and Medication for Opioid Use Disorder (MOUD) Among Women
Journal article   Peer reviewed

Stigma and Medication for Opioid Use Disorder (MOUD) Among Women

Jessica L. Chou, Rikki Patton, Shannon Cooper-Sadlo, Carsen Swan, David S. Bennett, Dara McDowell, Asif Zaarur and Barbara Schindler
International journal of mental health and addiction
14 Feb 2022
DOI: https://doi.org/10.1007/s11469-022-00768-3
Featured in Collection :   UN Sustainable Development Goals @ Drexel

Abstract

Life Sciences & Biomedicine Psychiatry Psychology Psychology, Clinical Science & Technology Social Sciences Substance Abuse
Opioid misuse is a massive public health crisis that is impacting women. In 2019, in the USA, 15,000 women fatally overdosed from opioids. Medication for opioid use disorder (MOUD) is an effective treatment that facilitates withdrawal management which promotes recovery of opioid use disorder. Yet, the stigma associated with OUD and MOUD as a treatment keeps some women with OUD from seeking treatment. The present study analyzed focus group data to understand experiences of stigma among women with opioid OUD who were receiving MOUD. Results indicated three themes: (1) "MOUD is still a drug," (2) Responses in coping with MOUD stigma, and (3) The value of peer support in MOUD treatment. Treatment considerations for women using MOUD include psychoeducation for family members and strategies to further incorporate peer support into MOUD treatment.

Metrics

21 Record Views
10 citations in Web of Science
9 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Psychiatry
Psychology, Clinical
Substance Abuse
Logo image